Latest filing published 14 Dec 2020 for Evoke Pharma Inc, €115k.
This profile gathers the share dealings of David A. Gonyer across 2 companies, led by Evoke Pharma Inc and Viridian Therapeutics, Inc.\DE. The record holds 14 filings, for trades running from 27 February 2015 to 14 December 2020.
No open-market purchase appears, only 2 sales worth €173k. Outside the open market, there are 1 share grant and 4 option exercises. So far in 2020, the count stands at no purchases and 2 sales.
The record was last updated on 14 December 2020 with an open-market sale (€58k) in Evoke Pharma Inc. The median gap between a trade and its publication by SEC (Form 4) is 3 days. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
14 of 14 declarations